NDC 82442-698 - Target Maximum Strength Cold Flu and Sore Throat Overnight Cold and Flu
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 82442-698
- Package NDCs from labels
- 82442-698-06
- Manufacturer
- TARGET CORPORATION
- Effective date
- 2026-11-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Maximum Strength Cold Flu and Sore Throat - TARGET CORPORATION | TARGET CORPORATION | 2026-11-10 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 82442-698-06 | Target Maximum Strength Cold Flu and Sore ThroatOvernight Cold and Flu | 180 mL in 1 BOTTLE | SOLUTION | 180 mL | 650 mg in 20mL | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 82442-698 | TARGET MAXIMUM STRENGTH COLD FLU AND SORE THROAT OVERNIGHT COLD AND FLU (ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL AND TRIPROLIDINE HCL) KIT [TARGET CORPORATION] | 6 | Unmatched | 20241109_6e94fdab-27ea-4c0f-a91c-735ce697304b.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| meijer Maximum Strength Nighttime Cough DM | DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE | MEIJER DISTRIBUTION INC | a99f36b1-6cf4-496e-a347-08aa21cba163 | 2026-10-05 | Warnings | M012 9D2RTI9KYH |
| Meijer Children Cough and Chest Congestion DM Grape Flavor | DEXTROMETHORPHAN HBR AND GUAIFENESIN | MEIJER DISTRIBUTION INC | 9121804a-e5eb-46a2-a4a7-cc625be846d1 | 2026-10-05 | Warnings | M012 9D2RTI9KYH 495W7451VQ |
| Meijer Maximum Strength Severe Congestion and Cough | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | MEIJER, INC. | 5d2b54e5-1cb7-4071-9de2-afae33536c49 | 2026-10-05 | Warnings | M012 9D2RTI9KYH 04JA59TNSJ 495W7451VQ |
| Meijer Adult Mucus Plus chest congestion | GUAIFENESIN | MEIJER DISTRIBUTION, INC | f6a23be6-0313-4c23-afb7-576666b80e21 | 2026-10-05 | Warnings | M012 495W7451VQ |
| PERCOCET | OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN | SpecGx LLC | 4dd36cf5-8f73-404a-8b1d-3bd53bd90c25 | 2026-10-02 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Daytime Cold and Cough and NightTime Cold and Congestion Childrens | BROMPHENIRAMINE MALEATE, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCL | TARGET Corporation | aea32721-a164-4eed-8eb6-f91a1ced20ef | 2026-10-02 | Warnings | M012 |
| Cold Relief Multi-Symptom | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL | Cardinal Health 110, LLC. DBA Leader | 0c94780d-e901-43fc-ad8a-80c5d61ea47b | 2026-10-02 | Warnings | M012 9D2RTI9KYH 04JA59TNSJ 362O9ITL9D |
| nasal mist | OXYMETAZOLINE HYDROCHLORIDE | CVS Pharmacy | b71c557a-eb93-40d1-87c4-847f5468fc1e | 2026-10-02 | Warnings | M012 |
| Multi-Symptom Mapap Cold Formula | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL | Major Pharmaceuticals | 97f548d8-df01-4650-88a4-7701ec2b9be2 | 2026-10-02 | Warnings | M012 9D2RTI9KYH 04JA59TNSJ 362O9ITL9D |
| Cough and Cold HBP | CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HBR | Chain Drug Marketing Association, Inc. | b00ec380-4e6e-4a3b-958c-50c75cff81a0 | 2026-10-02 | Warnings | M012 9D2RTI9KYH |
| Artifical Tears | GLYCERIN AND PROPYLENE GLYCOL | Wal-Mart Stores Inc | 99cfea82-afb8-4c5f-ac0c-492204a42c08 | 2026-10-02 | Warnings | 6DC9Q167V3 PDC6A3C0OX |
| Vicks DayQuil-D NyQuil-D COLD and SINUS plus SEVERE CONGESTION | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, GUAIFENESIN, PSEUDOEPHEDRINE HCL | The Procter & Gamble Manufacturing Company | 3c1cbe58-f5a2-c96e-e063-6294a90a74e6 | 2026-10-02 | Warnings | M012 |
| Vicks NyQuil-D COLD and SINUS plus SEVERE CONGESTION | ACETAMINOPHEN, PSEUDOEPHEDRINE HCL, DOXYLAMINE SUCCINATE, DEXTROMETHORPHAN HBR | The Procter & Gamble Manufacturing Company | 3c176ea9-62a0-b86f-e063-6294a90ab8f7 | 2026-10-02 | Warnings | M012 9D2RTI9KYH 362O9ITL9D |
| Vicks DayQuil-D COLD and SINUS plus SEVERE CONGESTION | ACETAMINOPHEN, GUAIFENESIN, PSEUDOEPHEDRINE HCL, DEXTROMETHORPHAN HBR | The Procter & Gamble Manufacturing Company | 3c1773cb-f56e-c396-e063-6294a90a736b | 2026-10-02 | Warnings | M012 9D2RTI9KYH 362O9ITL9D 495W7451VQ |
| Vicks Sinex Severe All in One Sinus | ACETAMINOPHEN, PHENYLEPHRINE HCL | The Procter & Gamble Manufacturing Company | 9a106398-6d9d-2146-e053-2995a90a3fdf | 2026-10-02 | Warnings | M012 04JA59TNSJ 362O9ITL9D |
| Vicks Sinex Severe All in One Sinus Mucus | ACETAMINOPHEN, PHENYLEPHRINE HCL, GUAIFENESIN | The Procter & Gamble Manufacturing Company | 9a106291-edda-2135-e053-2995a90a44fd | 2026-10-02 | Warnings | M012 04JA59TNSJ 362O9ITL9D 495W7451VQ |
| Vicks Sinex SEVERE CONGESTION | OXYMETAZOLINE HYDROCHLORIDE | Procter & Gamble Manufacturing GmbH | 4644c4ae-9607-d404-e063-6294a90aca24 | 2026-10-02 | Warnings | M012 |
| VICKS SINEX SEVERE CONGESTION ORIGINAL Ultra Fine Mist | OXYMETAZOLINE HYDROCHLORIDE | Procter & Gamble Manufacturing GmbH, | 4645336e-40d8-89e6-e063-6294a90a7655 | 2026-10-02 | Warnings | M012 |
| Vicks Sinex SEVERE CONGESTION MOISTURIZING ULTRA FINE MIST | OXYMETAZOLINE HYDROCHLORIDE | Procter & Gamble Manufacturing GmbH | 464534ee-15f8-3af8-e063-6394a90a3f18 | 2026-10-02 | Warnings | M012 |
| Vicks SINEX SEVERE CONGESTION VapoCOOL ULTRA FINE MIST | OXYMETAZOLINE HYDROCHLORIDE | Procter & Gamble Manufacturing GmbH | 464550b3-5970-aca5-e063-6294a90a5954 | 2026-10-02 | Warnings | M012 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.